<time datetime="2017-05-23T00:01:00-04:00">May 23, 2017</time>

The current methods of paying healthcare providers do not encourage systematic consideration of cost-effectiveness in the selection of treatment or new technologies, finds a new report from the C.…

<time datetime="2016-01-20T00:01:00-05:00">January 20, 2016</time>

Canadian governments must rethink healthcare on five areas of national priority, according to a new report from the C.D. Howe Institute. In “Challenging Vested Interests: National Priorities for…

<time datetime="2016-01-19T00:01:00-05:00">January 19, 2016</time>

Canadians would benefit from a new funding model for elder care, finds a new report from the C.D. Howe Institute. In “Shifting Towards Autonomy: A Continuing Care Model for Canada,” authors…

<time datetime="2013-04-17T13:45:51-04:00">April 17, 2013</time>

The dismal performance of Canada relative to other OECD countries on measures of wait times and access to hospitals underlines the need for rethinking the way hospitals are funded, according to a…

<time datetime="2012-01-31T14:45:46-05:00">January 31, 2012</time>

Canada’s provinces could learn from the Dutch and UK models as they seek better value for money in healthcare delivery, according to a new report from the C.D. Howe Institute. In Better Value…

<time datetime="2004-06-01T00:00:00-04:00">June 1, 2004</time>
Intelligence Memos
From: Åke Blomqvist and Paul Grootendorst To: Canadians Concerned about Drug Prices Date: October 12, 2021 Re: Price Regulation Not the Best Answer for Pharmaceuticals Big changes…
Op-Ed
Big changes are afoot in the way patent drugs are priced in Canada. At present, Canada’s Patented Medicine Prices Review Board (PMPRB), a federal agency, is responsible for setting maximum prices…
Intelligence Memos
From: Michael J. Trebilcock and Dan Poliwoda To: Canadians concerned about vaccine equity Date: September 23, 2021 Subject: The TRIPS Vaccine Waiver Controversy The vastly…